7 peptides under active FDA review PCAC MEETING IN 15 DAYS
FindLegitPeptides status board · v2.5.1
CagriSema Blend
Cagrilintide + Semaglutide fixed-dose combination, CagriSema
Not 503A eligible

No. Not currently eligible for pharmacy compounding.

Talk to a licensed clinician before acting on this.

Not eligible for compounding (unapproved investigational NDA product)

Blends

Same category

Related peptides

Before you spend a dollar: confirm the pharmacy is real, and know what a fair price looks like.